*Department of Laboratory Medicine and Pathobiology, University of Toronto, Vancouver, BC, Canada
Department of †Laboratory Hematology
§Pathology, University Health Network, Toronto, ON, Canada
‡Canadian Immunohistochemistry Quality Control (CIQC)/Canadian Association of Pathologists National Standards Committee for High Complexit Testing/Immunohistochemistry
∥Poundbury Cancer Institute
¶Dorset County Hospital NHS Foundation Trust
#Cancer Diagnostic Quality Assurance Services (CADQAScic), Dorchester, UK
***UK National External Quality Assessment Scheme (UK NEQAS), University College London, London, UK
**“Rudolf-Virchow-Haus”, Institute of Pathology, Charité—University Hospital Berlin, Berlin, Germany
††School of Medicine, Griffith University, Gold Coast
‡‡Genomics For Life, Brisbane, QLD
§§RCPA Quality Assurance Program, Sydney, NSW, Australia
∥∥Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada
¶¶International Quality Network for Pathology (IQN Path), Luxembourg City, Luxembourg, and Division of Cancer, Department of Surgery & Cancer, Imperial College London, UK
##Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
†††Center of Predictive Molecular Medicine, Center for Excellence on Ageing and Translational Medicine, University of Chieti-Pescara, Chieti, Italy
‡‡‡Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands
§§§Institute of Pathology, Aalborg University Hospital and Department of Clinical Medicine, Aalborg University, Denmark
∥∥∥Nordic Immunohistochemistry Quality Control (NordiQC), Aalborg, Denmark
¶¶¶Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB
###Department of Pathology, Beijing Friendship Hospital, Capital Medical University
****CCP-IHCQC, Chinese Committee for Pathologists—Immunohistochemistry Quality Control, Beijing, China
††††Keck School of Medicine, University of Southern California, Los Angeles, CA
The authors declare no conflict of interest.
Reprints: Emina E. Torlakovic, MD, PhD, Department of Laboratory Hematology, Toronto General Hospital/UHN, 200 Elizabeth Street, Toronto, ON, Canada M5G 2C4 (e-mail: [email protected]).
